Leukemia Clinical Trials in Atlanta

Showing 1161-1180 of 1,704 trials

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

NCT03579758

This phase III trial studies how well chemotherapy before and after surgery works in treating participants with gallbladder cancer that can be removed by surgery. Drugs used in chemotherapy, such as cisplatin, gemcitabine, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery may kill more tumor cells.

Stage I Gallbladder Cancer AJCC v8Stage II Gallbladder Cancer AJCC v8Stage IIA Gallbladder Cancer AJCC v8+4 more

Emory UniversityStarted Apr 2019

Stanford, California, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01154816

This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia. Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more

Children's Oncology Group118 participantsStarted Feb 2011

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Little Rock, Arkansas, United States +102 more locations

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Leukemia Trials in Other Cities

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Why do Oral Contraceptives Prevent Ovarian Cancer?

Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Other Conditions in Atlanta